Supports investigator-initiated prospective observational or biomarker validation studies through cooperative agreements. Funding covers studies requiring collection or continued analysis of data and biospecimens. Clinical trials are not allowed under this opportunity. Eligible applicants include a broad range of U.S. organizations; foreign entities are excluded.
Eligible applicants include a wide range of U.S. organizations such as state and local governments, nonprofits, small businesses, and institutions of higher education. Foreign organizations and foreign components of U.S. organizations are not eligible.
